Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00102700
Status:
COMPLETED
Last Update Posted:
2009-04-29
First Post:
2005-02-01
Brief Title:
ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
Sponsor:
ArQule Inc a subsidiary of Merck Sharp Dohme LLC a subsidiary of Merck Co Inc Rahway NJ USA
Organization:
ArQule Inc a subsidiary of Merck Sharp Dohme LLC a subsidiary of Merck Co Inc Rahway NJ USA